Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Wolters Kluwer is a Dutch information services and software provider serving professional markets including healthcare (clinical decision support, drug information databases), tax & accounting (CCH software suite), legal & regulatory (CT Corporation entity management), and corporate compliance. The company operates a mission-critical software model with 72.5% gross margins, serving over 180 countries with sticky subscription revenue from professionals who face regulatory mandates requiring their tools.
Wolters Kluwer operates a subscription-based SaaS model with 85%+ recurring revenue. Pricing power derives from regulatory mandates (tax compliance, clinical standards, corporate governance) that make switching costs prohibitively high. The company monetizes proprietary content databases combined with workflow software, charging per-user or per-entity fees. Expert solutions command premium pricing due to liability reduction and productivity gains for professionals. Digital transformation drives upsell from legacy print to higher-margin cloud platforms.
Organic revenue growth rate in Health division (UpToDate subscriber additions, hospital penetration rates)
Tax software recurring revenue retention and CCH cloud migration progress in North America
Expert solutions bookings growth and annual contract value expansion in GRC division
Currency translation impact from EUR/USD movements (50%+ revenue in Europe, reports in EUR but trades as ADR)
Margin expansion from digital mix shift and operational efficiency programs
M&A activity in fragmented compliance software markets
AI disruption to professional workflows: Large language models (ChatGPT, Claude) could commoditize legal research, tax guidance, and clinical decision support, threatening Wolters Kluwer's content moats and pricing power
Regulatory simplification risk: Tax code simplification or healthcare administrative burden reduction would reduce demand for compliance software and expert solutions
Open-source medical knowledge: Initiatives like Wikipedia for medicine or open-access clinical guidelines could erode UpToDate's subscription model over 10+ year horizon
Thomson Reuters and LexisNexis compete directly in legal/regulatory with comparable scale and content depth, creating pricing pressure in mature markets
Vertical SaaS specialists (Veeva in pharma, niche EHR vendors in healthcare) unbundle Wolters Kluwer's integrated offerings with superior user experience
Big Tech entry: Microsoft/Google could bundle compliance tools into Office 365/Workspace at marginal cost, particularly in tax and legal research
Elevated leverage (Debt/Equity 5.9x) limits M&A flexibility and creates refinancing risk if EBITDA declines or credit markets tighten
Current ratio of 0.71 indicates working capital deficit, though subscription model generates cash upfront mitigating liquidity concerns
Pension obligations in Netherlands and legacy defined benefit plans create unfunded liability risk if discount rates decline further
Currency mismatch: EUR functional currency but significant USD revenue creates translation volatility in reported results
low-to-moderate - Core Health and Tax & Accounting divisions are non-discretionary (regulatory compliance, clinical standards) providing recession resilience. However, GRC division faces headwinds during economic contractions as corporate clients defer compliance projects and reduce legal spending. Small/mid-sized accounting firm and law firm customers exhibit cyclical sensitivity. Overall revenue typically declines only 0-2% in recessions due to subscription model inertia, but new bookings growth slows materially.
Rising rates create moderate headwinds through three channels: (1) Higher discount rates compress valuation multiples for high-quality recurring revenue models trading at 16x P/B; (2) EUR-denominated debt servicing costs increase (Debt/Equity of 5.9x suggests material leverage); (3) Professional services clients (law firms, accounting practices) face financing pressure reducing technology budgets. However, the subscription model provides cash flow stability that partially offsets rate sensitivity. The 8.1% FCF yield provides some valuation support in rising rate environments.
Minimal direct credit exposure as the business operates B2B subscriptions with monthly/annual billing cycles and limited accounts receivable aging. However, indirect exposure exists through customer financial health - distressed hospitals, bankrupt law firms, or failing accounting practices represent churn risk. The high Debt/Equity ratio (5.9x) creates refinancing risk if credit spreads widen materially, though investment-grade rating and strong FCF provide cushion.
value/quality - The 60.5% one-year decline has compressed valuation to 2.3x P/S (likely below historical 3-4x range for quality recurring revenue businesses), attracting value investors seeking mean reversion. The 8.1% FCF yield and 92.4% ROE appeal to quality-focused funds. However, the -43.9% six-month return suggests momentum investors have exited. Dividend investors may be attracted if payout ratio is sustainable (not specified but typical for European info services). The sharp drawdown likely reflects multiple compression from rising rates rather than fundamental deterioration, creating potential value opportunity.
moderate - As a European ADR in professional services, the stock exhibits lower volatility than cyclical industrials but higher than pure-play SaaS due to: (1) Currency translation volatility from EUR/USD swings; (2) Quarterly earnings lumpiness in bookings-driven GRC division; (3) ADR liquidity constraints versus primary Amsterdam listing. The 60% drawdown is extreme for this business quality, suggesting technical factors or sector rotation rather than fundamental volatility. Historical beta likely 0.7-0.9 to broader market.